Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRK | NVO | PFE | ||
| Company | Merck & Company | Novo Nordisk A/S ADR | Pfizer Inc | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 110.71 | 59.91 | 25.89 | ||
| High | 110.73 | 62.40 | 25.89 | ||
| Low | 108.43 | 59.24 | 25.55 | ||
| Latest | 108.83 | 62.33 | 25.65 | ||
| Change | -2.14 | +5.21 | -0.24 | ||
| % Change | -1.93% | +9.12% | -0.93% | ||
| Volume | 14,852,000 | 43,376,900 | 59,470,500 | ||
| 20-Day Average Volume | 13,517,690 | 21,796,141 | 44,193,535 | ||
| Previous Close | 110.97 | 57.12 | 25.89 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 107.19 | 54.41 | 25.24 | ||
| 20-Day Raw Stochastic | 71.01% | 99.53% | 69.79% | ||
| 20-Day Relative Strength | 61.62 | 69.41 | 53.89 | ||
| Weighted Alpha | +24.80 | +3.38 | +0.69 | ||
| Today's Opinion | 100% Buy | 24% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 8% Buy | 88% Buy | ||
| Last Month's Opinion | 88% Buy | 88% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.54% since 01/09/26 | +5.99% since 01/09/26 | +0.67% since 01/09/26 | ||
| Low | 107.22 on 01/13/26 | 56.29 on 01/15/26 | 24.97 on 01/13/26 | ||
| High | 111.58 on 01/15/26 | 62.40 on 01/16/26 | 25.89 on 01/16/26 | ||
| 1-Month | |||||
| %Chg | +10.75% since 12/16/25 | +27.31% since 12/16/25 | +0.47% since 12/16/25 | ||
| Low | 98.06 on 12/17/25 | 47.51 on 12/18/25 | 24.83 on 01/02/26 | ||
| High | 112.90 on 01/08/26 | 62.40 on 01/16/26 | 26.00 on 01/06/26 | ||
| 3-Month | |||||
| %Chg | +29.68% since 10/16/25 | +11.12% since 10/16/25 | +5.86% since 10/16/25 | ||
| Low | 82.01 on 11/04/25 | 43.08 on 11/24/25 | 23.91 on 11/10/25 | ||
| High | 112.90 on 01/08/26 | 62.40 on 01/16/26 | 26.65 on 12/15/25 | ||
| 6-Month | |||||
| %Chg | +32.03% since 07/16/25 | -7.03% since 07/16/25 | +4.23% since 07/16/25 | ||
| Low | 76.66 on 07/29/25 | 43.08 on 11/24/25 | 23.11 on 08/01/25 | ||
| High | 112.90 on 01/08/26 | 71.79 on 07/25/25 | 27.69 on 10/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 270,118,560 | 278,303,456 | 145,838,416 | ||
| Shares Outstanding, K | 2,482,023 | 4,465,000 | 5,685,708 | ||
| Annual Sales | 64,168,000,000 | 42,108,430,000 | 63,627,000,000 | ||
| Annual Net Income | 17,117,000,000 | 14,643,260,000 | 8,031,000,000 | ||
| Last Quarter Sales | 17,276,000,000 | 11,741,240,000 | 16,654,000,000 | ||
| Last Quarter Net Income | 5,785,000,000 | 3,132,940,000 | 3,541,000,000 | ||
| 60-Month Beta | 0.29 | 0.66 | 0.47 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.58 on 10/30/25 | 1.02 on 11/05/25 | 0.87 on 11/04/25 | ||
| Latest Earnings Date | 02/03/26 | 02/04/26 | 02/03/26 | ||
| Most Recent Dividend | 0.850 on 12/15/25 | 0.412 on 08/18/25 | 0.430 on 11/07/25 | ||
| Next Ex-Dividends Date | 12/15/25 | 08/18/25 | 01/23/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 12.83 | 14.95 | 8.09 | ||